James Samuel Shannon, Director of Xilio Therapeutics XLO, has filed 3 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $44K. The latest trade was on 06/11.

JS

JS

James Samuel Shannon

Director

Company

Xilio Therapeutics XLO

First filing

23/05/02

Trades

23 trades

Buys / sales

3 / 0

12-month net buying

$44K

Last trade

06/11

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Xilio TherapeuticsXLO	Open-market buy	03/26	03/30	5,000 sh	$8.79	$43,950	+100.0%
Xilio TherapeuticsXLO	Open-market buy	25/06/16–25/06/17	25/06/18	70,000 sh2 trades	$0.69avg.	$48,300	No record